Dokter Kim Geybels Acute Geneeskunde SRL
Dokter Kim Geybels Acute Geneeskunde reported total assets of 319,035 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Dokter Kim Geybels Acute Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +84 % Total assets +88 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dokter Kim Geybels Acute Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 21,335 € | ||||
| Equity | 265,524 € | ||||
| Cash | 29,496 € | ||||
| EBITDA | 26,026 € | ||||
| Total assets | 319,035 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Dokter Kim Geybels Acute Geneeskunde's financial analysis
- Solvency83.2%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dokter Kim Geybels Acute Geneeskunde
1 active director(s) in the register.
Dokter Kim Geybels Acute Geneeskunde's shareholders and holdings →Dokter Kim Geybels Acute Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0826.068.430
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0826068430 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 May 2010
- Registered office
- 9830 Sint-Martens-Latem
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Medical specialists activities (NACE 86220)
Dokter Kim Geybels Acute Geneeskunde (SRL) has been based in Sint-Martens-Latem since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 21,335 € and equity of 265,524 €; its revenue is not published. Its solvency stands at 83.2%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dokter Kim Geybels Acute Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dokter Kim Geybels Acute Geneeskunde
What is the revenue of Dokter Kim Geybels Acute Geneeskunde?
Dokter Kim Geybels Acute Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dokter Kim Geybels Acute Geneeskunde?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dokter Kim Geybels Acute Geneeskunde. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0826068430. Its company number (CBE) is 0826.068.430.
Where is the registered office of Dokter Kim Geybels Acute Geneeskunde?
According to the CBE register, the registered office of Dokter Kim Geybels Acute Geneeskunde is in 9830 Sint-Martens-Latem.
What is the equity of Dokter Kim Geybels Acute Geneeskunde?
At the close of the 2025 financial year, the equity of Dokter Kim Geybels Acute Geneeskunde amounts to 265,524 €, a solvency of 83.2% of total assets.
Who manages Dokter Kim Geybels Acute Geneeskunde?
The register lists 1 active mandates at Dokter Kim Geybels Acute Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dokter Kim Geybels Acute Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →